StayCurrentMD · Pleuropulmonary Blastoma PDQ®
Follow
Guideline1 min read·Published Mar 2020Older

Pleuropulmonary Blastoma PDQ®

Guideline · Mar 2020 · 1 min read

In brief

In brief

NCI's evidence-based clinical reference for healthcare professionals managing pleuropulmonary blastoma, a rare pediatric thoracic malignancy. Covers diagnostic approaches, staging systems, treatment protocols, and genetic considerations including DICER1 syndrome screening for affected families.

  • Pleuropulmonary blastoma is a rare pediatric lung malignancy requiring specialized multidisciplinary treatment.
  • PDQ® provides evidence-based treatment guidelines for health professionals managing this rare childhood cancer.
  • Familial predisposition exists; genetic counseling may be indicated for affected families.

Written by the GCMD Library team from the guideline.

National Institute of Health and National Cancer Institute Childhood Pleuropulmonary Blastoma Treatment (PDQ®)–Health Professional Version

Read it at the source ↗

This guideline lives on cancer.gov.

Open it on cancer.gov ↗
Try
Intelligent Search· scoped to this guideline · not medical adviceSearch the whole library →